Skip to main content
Quest Diagnostics

Optimal Growth Hormone Response despite Low Insulin-Like Growth Factor-1: Clinical Picture of an A67T IGF-1 Variant

ENDO2024

Boston, MA, June 1-4, 2024

Poster presentation: Optimal Growth Hormone Response despite Low Insulin-Like Growth Factor-1: Clinical Picture of an A67T IGF-1 Variant

Authors: Bomberg EM, Wu Z, Motorykin I, Torkelson J, Schmitz N, Drilling A, McPhaul MJ, Miller BS

Specialty: Endocrinology, Cardiology, Cardiovascular disease

Related content

Audio Podcast
Laboratory Testing for the Diagnosis and Management of Thyroid Disorders
On-Demand Webinar
Innovative Solutions: LC-MS/MS
Publication
Detection Rate of IGF-1 Variants and Their Implication to Protein Binding: Study of Over 240,000 Patients
Publication
Isotopic Peak Index, Relative Retention Time, and Tandem MS for Automated High Throughput IGF-1 Variants Identification in a Clinical Laboratory

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.